Skip to search formSkip to main contentSkip to account menu

DNM3 gene

Known as: Dyna III, DYNAMIN 3, DNM3 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Genetic variability in DNM3 has been shown to modify age of onset of Parkinson's disease (PD) among LRRK2 Gly2019Ser carriers in… 
2018
2018
Long non-coding RNAs (lncRNAs) are closely associated with the regulation of various biological processes and are involved in the… 
Review
2017
Review
2017
Dynamin 3 comes from an ancient family of GTPase, who encodes 3 classical genes but share the basic structure composing of… 
2016
2016
.......................................................................................................................................... ii Preface............................................................................................................................................ iv Table of contents ............................................................................................................................ vi List of tables ................................................................................................................................... ix List of figures ................................................................................................................................. xi List of abbreviations .................................................................................................................... xiii Glossary of terms ........................................................................................................................ xvii Acknowledgments........................................................................................................................ xix 1. Chapter 1: Introduction ....................................................................................................... 1 1.1. General features of Parkinson disease ........................................................................ 1 1.1.1. Motor features ..................................................................................................... 1 1.1.2. Non-motor features ............................................................................................. 2 1.1.3. Pathology ............................................................................................................ 2 1.2. Identification of genetic mutations in PD ................................................................... 3 1.2.1. Linkage analysis.................................................................................................. 3 1.2.2. Next generation sequencing ................................................................................ 4 1.2.3. Genome-wide case-control association............................................................... 5 1.3. Genes implicated in late-onset autosomal dominant PD ............................................ 6 1.3.1. SNCA .................................................................................................................. 6 1.3.2. LRRK2 ................................................................................................................ 7 1.3.3. MAPT ................................................................................................................. 8 1.3.4. EIF4G1 ................................................................................................................ 9 1.3.5. VPS35 and DNAJC13....................................................................................... 10 1.3.6. CHCHD2........................................................................................................... 11 1.3.7. Recessively inherited gene mutations ............................................................... 12 1.4. GWAS in PD............................................................................................................. 13 1.5. Neurobiological interactions: is there one pathway for PD? .................................... 20 1.6. Reduced penetrance .................................................................................................. 23 2. Chapter 2: Disease penetrance estimates of mutations in late-onset PD .......................... 25 2. 
2012
2012
The authors of the above article noticed an error in publication of this paper (online publication 2 February 2012) in the… 
2007
2007
DOI: 10.1038/nrn2270 Dendrites contain hundreds of distinct postsynaptic sites that are compartmentalized into individual spines… 
2006
2006
Amyloid precursor protein (APP) has been the subject of intense research to uncover its implication in Alzheimer's disease. Its…